GABRA4 Antilichaam - N-terminalgebied: FITC (ARP34982_P050-FITC)

Gamma-aminobutyric acid (GABA) A receptor, alpha 4

2557

P48169

NP_000800

Human, Rat, Cow, Horse, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human GABRA4

GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

DGAT1; APP; PRKCG

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Cow: 86%; Horse: 79%; Human: 100%; Rabbit: 93%; Rat: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

58kDa

Agrawal, A., (2008) Addiction 103 (6), 1027-1038

Wet Ice

554

GABRA4

GABRA4

Rabbit

Gamma-aminobutyric acid receptor subunit alpha-4

NM_000809

MVSAKKVPAIALSAGVSFALLRFLCLAVCLNESPGQNQKEEKLCTENFTR

Alpha-4